CLINICAL_TRIALS
trial_result
· 2020-07-23
Clinical Trial Update: Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure [Phase 4]
Summary
Phase 4 trial investigating flumazenil for hypoactive delirium due to benzodiazepine exposure; study terminated with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Davis | Conditions: Hypoactive Delirium | Phase 4 | Status: TERMINATED | Results posted: 2020-07-23